Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001567619-19-002917
Filing Date
2019-02-11
Accepted
2019-02-11 11:03:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 64389
  Complete submission text file 0001567619-19-002917.txt   66138
Mailing Address 399 PARK AVE NEW YORK NY 10022
Business Address 399 PARK AVE NEW YORK NY 10022 2127563300
FIRST MANHATTAN CO (Filed by) CIK: 0000728083 (see all company filings)

EIN.: 131957714 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48710 | Film No.: 19583118
SIC: 2834 Pharmaceutical Preparations